Indivior Pharmaceuticals, Inc.
INDV
$36.76
-$1.07-2.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 3,700.00% | 2,900.00% | 241.76% | 143.55% | 93.75% |
| Total Depreciation and Amortization | -24.00% | -20.00% | 75.00% | 118.18% | 127.27% |
| Total Amortization of Deferred Charges | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 27.91% | -100.00% | -61.80% | -37.61% | -69.72% |
| Change in Net Operating Assets | -620.24% | -458.70% | 86.03% | 121.74% | 124.35% |
| Cash from Operations | -175.00% | -175.00% | 183.10% | 212.37% | 149.17% |
| Capital Expenditure | -153.13% | -127.59% | -241.18% | -275.00% | -255.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.59% | -100.00% | -73.91% | 29.41% | 0.00% |
| Cash from Investing | -305.13% | -195.65% | -148.57% | -38.24% | -31.58% |
| Total Debt Issued | 47.29% | -- | -- | -- | -- |
| Total Debt Repaid | -42.39% | 92.92% | -6,350.00% | -12,450.00% | -- |
| Issuance of Common Stock | -50.00% | -33.33% | -33.33% | -50.00% | -50.00% |
| Repurchase of Common Stock | 2.61% | 91.79% | 64.89% | 13.24% | -51.49% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 150.00% | -- | -100.00% | 0.00% |
| Cash from Financing | 90.48% | 70.59% | 108.29% | 74.81% | 35.71% |
| Foreign Exchange rate Adjustments | -- | -- | -100.00% | 0.00% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -258.87% | -4,233.33% | 148.92% | 171.72% | 136.47% |